Paddy Mullaney to Co-CEOs of the Group and members of Clondalkin's Board of Directors.
David Lennon has been with the Group for five years and currently oversees the Group's Specialist Packaging operations, which includes the Pharmaceutical & Healthcare and Consumer businesses. Under David's stewardship, the division has gained strength as a leading global producer of secondary pharmaceutical packaging, delivering strong operating performance and building a world class management team. David will continue to lead the Specialist Packaging operations on a day to day basis.
Paddy Mullaney has been with Clondalkin for over 20 years and most recently served as the Chief Operating Officer of Clondalkin's Flexible Packaging operations. Paddy has been instrumental in driving performance and better integrating the various business units and plant operations into a more cohesive division. Going forward, Paddy will assume day to day responsibility of the Flexible Packaging operations.
Mark Burgess will continue as Chairman of Clondalkin, supporting the Group in a non-executive capacity.
Mark Burgess, commented "Clondalkin has made significant progress over the past 12 months and now is the right time to further build the leadership team at both the Group and divisional level. As we look forward, our main focus is to provide market leading products and service to our customers, drive sales, and deliver on further operational initiatives to grow the business profitably. David and Paddy are uniquely qualified to lead the organization in their new roles and will do a great job doing so."
Clondalkin Group is a value-added packaging business with a broad and diversified geographic footprint. It's a market leader in secondary healthcare packaging and holds leading positions in flexible packaging markets in foils and laminate packaging with strong and long lasting customer relationship.
The Group has 35 manufacturing locations in eight countries, 4,000 employees and annual sales of €700million.